Study on symptoms of ethanol in breast cancer patients
Part of Cancer, Skin clinical trials.
This trial checks how breast cancer patients react to ethanol (alcohol) during chemotherapy with docetaxel. It aims to understand side effects and safety for people getting this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast cancer confirmed by biopsy
- You need to be scheduled for chemotherapy with docetaxel that does not contain ethanol
- You must be willing to sign a consent form and follow the study procedures
- You cannot have any other cancer that might affect your breast cancer treatment
- You cannot have breast cancer that has spread to other parts of the body (Stage IV) or is at an early stage (Stage 0 or 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a digital program that helps women understand how alcohol affects their risk of breast cancer. If you are a woman 40+ who drinks regularly, this program may help you make more informed health choices during your next screening visit.
This study looks at whether chemotherapy for breast cancer causes changes in your sense of taste. By tracking this side effect, doctors hope to better support patients during treatment.
This Phase 4 study tests an additional (adjuvant) treatment for breast cancer after surgery and standard follow-up care. It may help lower the chance the cancer comes back, but you must match specific tumor and body-chemistry requirements to join.
This study looks at whether body fat and muscle (body composition) change how well certain chemotherapy works after surgery for early breast cancer. You may be considered if you are planned to receive docetaxel as adjuvant (after-surgery) chemotherapy and have recent CT scan images.
This trial tests a new drug that targets breast cancer cells with low levels of the HER2 protein. It may offer a new treatment option for patients whose cancer has spread and not responded well to previous therapies.
This trial is comparing two types of chemotherapy (standard taxane vs a newer albumin-bound paclitaxel) given after surgery to see which is better at preventing breast cancer from returning. It is for women with HER2-negative breast cancer that has a high risk of coming back.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.